ENGEMYCIN DD DIN 02304236
Status: Marketed
Holder: INTERVET CANADA CORP
Available to quote
Health Canada record
| Active ingredient(s) | OXYTETRACYCLINE (OXYTETRACYCLINE HYDROCHLORIDE) 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 20-Aug-2025 |
| Current status date | 20-Aug-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OXYTETRACYCLINE (OXYTETRACYCLINE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00439339 | KELAMYCIN INTRAUTERINE SUSPENSION | WENDT LABS | Suspension | OXYTETRACYCLINE (OXYTETRACYCLINE HYDROCHLORIDE) 50 MG | Marketed |
| 02231105 | BIG COUNTRY MEDICATED T.V. SPECIAL | BIG COUNTRY AGRI-FEEDS LTD. | Powder | OXYTETRACYCLINE (OXYTETRACYCLINE HYDROCHLORIDE) 50 MG; CALCIUM D-PANTOTHENATE 3 MG; VITAMIN B12 3.5 MCG; NICOTINAMIDE 3.5 MG; VITAMIN B2 0.7 MG; VITAMIN D3 240 UNIT; VITAMIN A (VITAMIN A) 1200 UNIT | Cancelled Post Market |
| 02266105 | OXY-MED | ZOETIS CANADA INC | Powder For Solution | OXYTETRACYCLINE (OXYTETRACYCLINE HYDROCHLORIDE) 92.8 G | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34787 | 2025-02-05 | Supplement to an Abbreviated New Drug Submission (SANDS) | Data in support the reactivation of the DIN |
| 9273 | 2008-01-07 | Abbreviated New Drug Submission (ANDS) |